Growth Metrics

Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2025)

Collegium Pharmaceutical has reported Goodwill & Intangibles over the past 10 years, most recently at $815.4 million for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $815.4 million for Q4 2025, down 22.61% from a year ago — trailing twelve months through Dec 2025 was $815.4 million (down 22.61% YoY), and the annual figure for FY2025 was $815.4 million, down 22.61%.
  • Goodwill & Intangibles for Q4 2025 was $815.4 million at Collegium Pharmaceutical, down from $870.9 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for COLL hit a ceiling of $1.1 billion in Q3 2024 and a floor of $268.7 million in Q4 2021.
  • Median Goodwill & Intangibles over the past 5 years was $739.3 million (2022), compared with a mean of $710.8 million.
  • Biggest five-year swings in Goodwill & Intangibles: soared 280.45% in 2022 and later plummeted 55.16% in 2024.
  • Collegium Pharmaceutical's Goodwill & Intangibles stood at $268.7 million in 2021, then surged by 160.92% to $701.2 million in 2022, then fell by 20.77% to $555.6 million in 2023, then skyrocketed by 89.67% to $1.1 billion in 2024, then decreased by 22.61% to $815.4 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $815.4 million (Q4 2025), $870.9 million (Q3 2025), and $928.4 million (Q2 2025) per Business Quant data.